These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8606640

  • 1. Antiobesity effect of diazoxide in obese Zucker rats.
    Alemzadeh R, Jacobs W, Pitukcheewanont P.
    Metabolism; 1996 Mar; 45(3):334-41. PubMed ID: 8606640
    [Abstract] [Full Text] [Related]

  • 2. Modification of insulin resistance by diazoxide in obese Zucker rats.
    Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J.
    Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209
    [Abstract] [Full Text] [Related]

  • 3. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats.
    Alemzadeh R, Holshouser S.
    Endocrinology; 1999 Jul; 140(7):3197-202. PubMed ID: 10385415
    [Abstract] [Full Text] [Related]

  • 4. Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats.
    Alemzadeh R, Holshouser S, Massey P, Koontz J.
    Eur J Endocrinol; 2002 Jun; 146(6):871-9. PubMed ID: 12039709
    [Abstract] [Full Text] [Related]

  • 5. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
    Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M.
    Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
    [Abstract] [Full Text] [Related]

  • 6. Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats.
    Standridge M, Alemzadeh R, Zemel M, Koontz J, Moustaid-Moussa N.
    FASEB J; 2000 Mar; 14(3):455-60. PubMed ID: 10698960
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
    Alemzadeh R, Fledelius C, Bodvarsdottir T, Sturis J.
    Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
    [Abstract] [Full Text] [Related]

  • 8. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
    Alemzadeh R, Zhang J, Tushaus K, Koontz J.
    Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
    Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1911-5. PubMed ID: 9626118
    [Abstract] [Full Text] [Related]

  • 10. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
    Alemzadeh R, Tushaus KM.
    Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
    [Abstract] [Full Text] [Related]

  • 11. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
    Alemzadeh R, Tushaus K.
    Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
    [Abstract] [Full Text] [Related]

  • 12. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
    Sumner AE, Kushner H, Sherif KD, Tulenko TN, Falkner B, Marsh JB.
    Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906
    [Abstract] [Full Text] [Related]

  • 13. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
    Bergeron R, Previs SF, Cline GW, Perret P, Russell RR, Young LH, Shulman GI.
    Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
    [Abstract] [Full Text] [Related]

  • 14. Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats.
    Noshiro O, Hirayama R, Shimaya A, Yoneta T, Niigata K, Shikama H.
    Int J Obes Relat Metab Disord; 1997 Feb; 21(2):115-21. PubMed ID: 9043965
    [Abstract] [Full Text] [Related]

  • 15. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
    Yki-Järvinen H, Taskinen MR.
    Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
    [Abstract] [Full Text] [Related]

  • 16. Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.
    Oakes ND, Thalén P, Hultstrand T, Jacinto S, Camejo G, Wallin B, Ljung B.
    Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R938-46. PubMed ID: 16183630
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats.
    Muñoz MC, Giani JF, Dominici FP, Turyn D, Toblli JE.
    J Hypertens; 2009 Dec; 27(12):2409-20. PubMed ID: 19901849
    [Abstract] [Full Text] [Related]

  • 18. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
    De Gennaro-Colonna V, Rossoni G, Cocchi D, Rigamonti AE, Berti F, Muller EE.
    J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
    [Abstract] [Full Text] [Related]

  • 19. Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion.
    Arner P, Bolinder J, Engfeldt P, Hellmér J, Ostman J.
    J Clin Invest; 1984 Mar; 73(3):673-80. PubMed ID: 6368586
    [Abstract] [Full Text] [Related]

  • 20. Defective metabolic effects of norepinephrine and insulin in obese Zucker rat brown adipose tissue.
    Marette A, Géloën A, Collet A, Bukowiecki LJ.
    Am J Physiol; 1990 Feb; 258(2 Pt 1):E320-8. PubMed ID: 2154935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.